Recommendations for the medical treatment of ADHD in comorbid, substance-related disorders
Gemeinsame Suchtkommission der DGKJP, BAG KJPP und BKJPP (2025)
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 53(1), 31-39
Abstract
Position paper on ADHD pharmacotherapy in comorbid substance use disorders. Explicitly advises against bupropion and defines conditions for stimulant treatment.
Categories: Medikamente, Therapie
Keywords: comorbidity, substance use disorder, bupropion, stimulants, off-label